Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2021-05-25 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
EMTN update: publication of Prospectus
Regulatory Filings Classification · 99% confidence The document is titled "BASE PROSPECTUS" and details a US$10,000,000,000 Euro Medium Term Note Programme established by AstraZeneca PLC and AstraZeneca Finance LLC. It explicitly mentions compliance with the UK Prospectus Regulation and approval by the UK Financial Conduct Authority (FCA). A prospectus is a legal document required for offering securities to the public, detailing the terms, risks, and structure of the offering. This document is not an Annual Report (10-K), an Interim Report (IR), an Earnings Release (ER), or a simple announcement of a report (RPA/RNS). It is a core offering document related to financing activities. While it relates to capital structure, the specific nature of a 'Base Prospectus' for issuing Notes (debt securities) aligns most closely with documents related to fundraising and financing activities, which falls under the 'Capital/Financing Update' category (CAP), as it outlines the framework for issuing debt securities.
2021-05-25 English
EMTN programme update - publication of Prospectus
Regulatory Filings Classification · 98% confidence The document is a short announcement (3300 chars) released via RNS (RNS Number: 6580Z) on May 25, 2021. The title explicitly states 'EMTN programme update: publication of Prospectus'. The text confirms that a Prospectus has been approved by the FCA and is now available for viewing, providing a direct link to the PDF and noting submission to the National Storage Mechanism. According to Rule 2, when a document is short and announces the publication of another document (like a Prospectus), it should be classified as a Report Publication Announcement (RPA). While it is a regulatory filing (RNS), RPA is more specific for announcements about the release of reports/prospectuses.
2021-05-25 English
424B2
Prospectus
2021-05-24 English
F-3ASR
Regulatory Filings
2021-05-24 English
FORM 6-K
Foreign Filer Report
2021-05-24 English
425 Filing
Regulatory Filings
2021-05-24 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.